Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis.

Tia C L Kohs Christina U LorentzJ JohnsonC PuyS R OlsonJ J ShatzelDavid Gailani Monica T HindsE I TuckerAndrás Gruber Owen J T McCarty Michael Wallisch

Published in: Cellular and molecular bioengineering (2020)

Selective contact activation inhibitors hold potential as useful tools for research applications as well as safe and effective inhibitors of vascular device-related thrombosis.

Keyphrases

pulmonary embolism
signaling pathway
risk assessment
human health
climate change